Document is current
Any future updates will be listed below
-
Authors
Romano, Isabella G.
Johnson-Weaver, Brandi
Core, Susan B.
Jamus, Andzoa N.
Brackeen, Marcus
Blough, Bruce
Dey, Subhakar
Huang, Yumei
Staats, Herman
Wetsel, William C.
Chackerian, Bryce
Frietze, Kathryn M.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (F31DA059236, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123, UG3DA053123)
National Center for Advancing Translational Sciences (UL1TR001449)
Dedicated Health Research Funds from the University of New Mexico School of Medicine
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 11 March 2025
First Online: 28 March 2025
Competing interests
: B. Chackerian has equity in Metaphore Biotechnologies. B. Chackerian, S.B. Core, and K.M. Frietze are inventors on patent application 17/796,368 which covers the vaccines described in this manuscript. All other authors have no competing interests.
